血清IgE或血嗜酸性粒细胞计数能否预测慢性鼻窦炎伴鼻息肉术后口服糖皮质激素的疗效?
研究纳入236例双侧慢性鼻窦炎伴鼻息肉(CRSwNP)患者,随机接受口服糖皮质激素(OCS)15 mg每日两次或安慰剂治疗2周,评估术后6个月的主观VAS、SNOT-22和客观LKES评分。结果显示术后OCS未显著影响双侧CRSwNP结局,sIgE和血嗜酸性粒细胞计数(BEC)可能不是预测术后OCS疗效的替代生物标志物,OCS可能增加短暂睡眠障碍风险。
要点
- 术后口服糖皮质激素未显著改善双侧CRSwNP患者的VAS、SNOT-22和LKES评分。
- 血清IgE和血嗜酸性粒细胞计数可能不是预测术后OCS疗效的替代生物标志物。
- OCS可能增加短暂睡眠障碍风险。
核心结论
- 术后口服糖皮质激素未显著影响双侧CRSwNP结局。
- sIgE水平和BEC可能不是评估术后OCS作用的替代预测生物标志物。
- OCS可能增加短暂睡眠障碍风险。
研究设计与样本
- 研究纳入236例接受内镜鼻窦手术(ESS)的双侧CRSwNP患者,随机分配接受OCS 15 mg每日两次或安慰剂治疗2周,随访6个月。
- 术前按sIgE <150 IU/mL、sIgE ≥150 IU/mL、BEC <0.39×10^9 cells/L、BEC ≥0.39×10^9 cells/L进行亚组分层。
- 共193例参与者完成至6个月随访。
主要发现
- sIgE与BEC之间未观察到明显的线性关系。
- 在主分析中,VAS、SNOT-22和LKES评分在各随访时间点之间未发现显著差异。
- 在sIgE或BEC的主分析或亚组分析中,随访1个月时睡眠功能障碍的纵向评分观察到显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterised by inflammatory mucosa and polyp formation in the paranasal sinuses. The study's primary objective was to evaluate the outcomes of postoperative oral corticosteroid (OCS) in treating patients with bilateral CRSwNP. The secondary objective was to determine whether preoperative serum IgE levels (sIgE)and/or blood eosinophil count (BEC) correlate with postoperative outcomes following OCS use. METHODS: Patients with bilateral CRSwNP (n=236) who underwent endoscopic sinus surgery (ESS) were randomly assigned to receive 15 mg OCS twice daily or a placebo for 2 weeks. We investigated the treatment effects based on the subjective visual analogue scale (VAS), Sino-Nasal Outcome Test 22 (SNOT-22), and objective Lund-Kennedy Endoscopy Score (LKES) over 6 months; subgroups were stratified preoperatively as follows: sIgE <150 IU/mL, sIgE>=150 IU/mL, BEC <0.39x10(9) cells/L, and BEC>=0.39x10(9) cells/L. RESULTS: A total of 193 participants completed the study up to the 6-month follow-up; no apparent linear relationship was noted between sIgE and BEC. No significant differences in scores were noted upon assessment of the VAS, SNOT-22, and LKES among the follow-up timepoints in the primary analysis. However, in the primary or subgroup analyses with sIgE or BEC, significant differences in the longitudinal scores of sleep dysfunction were observed at the 1-month follow-up. CONCLUSION: Postoperative OCS did not significantly affect bilateral CRSwNP outcomes. sIgE levels and BEC may not be surrogate predictive biomarkers to assess the role of postoperative OCS use. OCS may increase the risk of transient sleep disturbance.
引用
- Shen KH, Jiang JY, Hsu PY, et al. Can serum IgE or blood eosinophil count predict postoperative oral corticosteroid response in chronic rhinosinusitis with nasal polyps? Rhinology. 2024. PMID: 37942939. doi:10.4193/Rhin23.124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。